期刊文献+

非小细胞肺癌p53、增殖细胞核抗原表达及其意义

Expression of p53,proliferating cell nuclear antigen in non-small cell lung carcinoma and it’s significance
下载PDF
导出
摘要 目的 :研究非小细胞肺癌 (NSCLC)中p5 3及增殖细胞核抗原 (PCNA)表达与细胞增殖的关系。方法 :采用免疫组化法(S P法 )检测 6 0例NSCLC中 p5 3和PCNA表达情况。 结果 :在NSCLC中 p5 3表达率 (5 3.3% )及PCNA增殖指数均高于癌旁组织 (P <0 .0 0 1~P <0 .0 5 ) ,且两者表达与淋巴结转移、临床分期和临床病理分级有一定关系 (P <0 .0 5~P <0 .0 0 5 )。p5 3、PCNA表达与组织类型无相关性 (P >0 .0 5 )。 结论 :p5 3参与了NSCLC的发生发展与淋巴结转移、临床分期及肿瘤分化程度相关。有促进细胞增殖的作用 ,在肿瘤的诊断及预后评估中具有重要意义。 Objective:To study the relationship between the expression of p53,proliferating cell nuclear antigen(PCNA) and cell proliferaive activity of non-small cell lung carcinoma(NSCLC).Methods:The expression of p53,PNCA was studied in 60 cases of NSCLC by S-P immunohistochemical method.Results:The positive rate of p53 in NSCLC was 53.3%,which was higher than that in the per cancerous tissues(P<0.001 to P<0.05).There was positive correlation between p53 expression and lymph node metastasis,clinical stage and pathological grade(P<0.05 to P<0.005),but there was no statistically correlation between p53 expression and histological type(P>0.05).Conclusions:p53 protein,which may have some effects on genesis and development of tumor,relates to lymph node metastasis,clinical stage and degree of differentiation of NSCLC,and increases tumor cell proliferations.The examination of p53 protein has value great in the assessment of prognosis and diagnosis of lung cancer.
出处 《蚌埠医学院学报》 CAS 2004年第4期293-295,共3页 Journal of Bengbu Medical College
基金 皖南医学院中青年科研资助项目 (WK2 0 0 3 18A)
关键词 非小细胞肺 P53 增殖细胞核抗原 免疫组织化学 预后 carcinoma,non-small-cell lung p53 proliferating cell nuclear antigen immunohistochemistry prognosis
  • 相关文献

参考文献6

二级参考文献57

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2Yamamoto T, Oda K, Kubota T, et al.Expression of p73 gene, cell proliferation and apoptosis in breast cancer: lmmunohistochemical and clinlcalpathological study[J]. Oncol Rep, 2002, 9:729 - 735.
  • 3Hirao A, Kong YY, Matsuoka SH, et al. DNA damage-induced activation of p53 by the checkpoint kinase chk2[J].Science, 2000, 287: 1824-1827.
  • 4Banin SL, Moyal SY, Shieh Y , et al.Enhanced phosphorylation of p53 by ATM in response to DNA damage[J].Science. 1998. 281:1674 - 1677.
  • 5Canman CE, Lim KA, Cimorich Y, et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53[J]. Science, 1998, 281:1677 -1679.
  • 6Zhou BP, Liao Y, Xia W, et al.Her-2/neu induces p53 ubiquitination via AKT-mediated mdm2 phosphorylation[J]. Nature Cell Biol, 2001,3:973 - 982.
  • 7Buschmann T, Fuchs SY, Lee CG, et al. SUMO-modification of MDM2 prevents its self-ubiquitination and increase mdm2 ability to ubiquitinate p53[J]. Cell, 2000, 101:753-762.
  • 8Baror RL, Ruth M, Segel Lee A, et al.Generation of oscillations by the p53-mdm2 feedback loop: A theoretical and experimental study[J]. Proc Natl Acad Sci USA, 2000, 97: 11250-11255.
  • 9Tolbert D, Lu XD, Yin CY, et al.p19ARF is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo[J]. Mol Cell Bid, 2002, 22:370 - 377.
  • 10Xirodimas D, Saville MK, Edling C, et al. Different effects of p14ARF on the levels of ubiquitinated p53 and MDM2 in vivo[J]. Oncogene, 2001,20:4912 - 4983.

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部